SRNE
Sorrento Therapeutics, Inc.
SRNE
SRNE
Delisted
SRNE was delisted on the 22nd of February, 2023.
218 hedge funds and large institutions have $656M invested in Sorrento Therapeutics, Inc. in 2021 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 67 increasing their positions, 52 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
218
Holders Change
+8
Holders Change %
+3.81%
% of All Funds
3.83%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.04%
New
30
Increased
67
Reduced
52
Closed
18
Calls
$75.2M
Puts
$38.4M
Net Calls
+$36.8M
Net Calls Change
-$13M
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
+$15.7M |
| 2 |
BlackRock
New York
|
+$13.4M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$10.5M |
| 4 |
D.E. Shaw & Co
New York
|
+$8.72M |
| 5 |
Norges Bank
Oslo,
Norway
|
+$5.44M |
Top Sellers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$4.3M |
| 2 |
Capital Fund Management (CFM)
Paris,
France
|
-$3.19M |
| 3 |
Citigroup
New York
|
-$1.67M |
| 4 |
Millennium Management
New York
|
-$1.66M |
| 5 |
HW
Hancock Whitney
Gulfport,
Mississippi
|
-$1.21M |
